Showing 431-440 of 2050 results for "".
Beyond the Diopter: Myopia’s Mark on the Retina and Choroid
https://modernod.com/topics/myopia/beyond-the-diopter-myopias-mark-on-the-retina-and-choroid/39832/Watch out for posterior segment complications in this patient population.GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
https://modernod.com/series/2419-ga/ga-cases-primary-eye-care-clinic-can-you-spot-the-three-signs/30027/Drs. Modi and Mammo highlight the criteria for defining atrophy based on OCT findings and present a case.Rationalizing the Red: When RNFL Atrophy Is Not Glaucoma
https://modernod.com/topics/glaucoma/rationalizing-the-red-when-rnfl-atrophy-is-not-glaucoma/38989/Having as much information as possible is essential for proper diagnosis and treatment.Could it be KC (KERATOCONUS)?
https://modernod.com/mod-issues/supplements-inserts/could-it-be-kc-keratoconus-kc-file-2-autorefractor-clues-that-were-ignored/38795/KC File #2: Autorefractor Clues That Were IgnoredShifting the Paradigm
https://modernod.com/mod-issues/supplements-inserts/shifting-the-paradigm-1/38427/What topical approach could mean for early treatment of diabetic retinopathy.Glaucoma Pipeline 2022
https://modernod.com/mod-issues/januaryfebruary-2022-insert/glaucoma-pipeline-2022/38375/Our second annual look into ongoing innovation.AvaGen™, The Genetic Eye Test in Modern Practice
https://modernod.com/mod-issues/supplements-inserts/avagen-the-genetic-eye-test-in-modern-practice-1/38330/How can the addition of genetic data guide treatment decisions?Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
https://modernod.com/specialty/optometry/adcs-pretreatment-assessment-2421/32361/Learn more about pretreatment assessment and ocular toxicity management for patients treated with antibody drug conjugates.GA Cases in the Primary Eye Care Clinic: Referring Earlier
https://modernod.com/series/2419-ga/ga-cases-primary-eye-care-clinic-referring-earlier/30026/Drs. Modi and Pecen present cases and discuss what OCT biomarkers to look for when determining when to refer a patient for GA treatment.Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
https://modernod.com/specialty/optometry/Sustaining-Vision-Empowering-Optometry-for-Tomorrows-Retinal-Care/32392/Join Drs. Khanani, Sheth, and Vajzovic, to learn how to educate patients about alternative treatment options for retinal diseases.